Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nebulized In-line Endotracheal Dornase Alfa and Albuterol Administered to Mechanically Ventilated COVID-19 Patients: A Case Series

NCT04387786 is registered in ClinicalTrials.gov with Feinstein Institute for Medical Research as lead sponsor.

NCT NCT04387786
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04387786 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nebulized In-line Endotracheal Dornase Alfa and Albuterol Administered to Mechanically Ventilated COVID-19 Patients: A Case Series
Lead sponsor
Feinstein Institute for Medical Research
Phase
Observational
Overall status
Completed
Start date
March 31, 2020
Completion date
September 4, 2020
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, mechanical ventilation